PhoenixBio is thrilled to be attending the European Society of Gene & Cell Therapy Meeting in person at the Edinburgh International Conference Centre in Edinburgh, UK from October 11th - 14th, 2022.
Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance future therapies for viral hepatitis (HBV, HDV/HBV, HCV), Gene Editing, Gene Therapy, Drug Metabolism, Pharmacokinetics, and Toxicology. With over two decades of humanized liver mouse model research, our team has extensively covered everything from human hepatocyte delivery (transduction via AAVs, transfection via LNPs, etc) to target engagement and efficacy evaluation.
While you're there, be sure to meet with our team members to discuss our humanized liver technology & study services:
